Quick Answer
Matinas BioPharma Holdings, Inc. reported Stockholders Equity of $4.83 million for fiscal year 2025.
Matinas BioPharma Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $4.83M | -36.4% |
| 2024 | $7.59M | -60.6% |
| 2023 | $19.25M | -47.5% |
| 2022 | $36.64M | -30.2% |
| 2021 | $52.49M | -17.6% |
| 2020 | $63.73M | +92.8% |
| 2019 | $33.05M | +104.8% |
| 2018 | $16.14M | +51.1% |
| 2017 | $10.68M | +49.4% |
| 2016 | $7.15M | +17.7% |
| 2015 | $6.07M | +172.6% |
| 2014 | $2.23M | -78.7% |
| 2013 | $10.47M | +9084.1% |
| 2012 | -$116.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.46M | -59.1% | -15.8% |
| June 30, 2025 | $7.67M | -59.8% | +22.4% |
| March 31, 2025 | $6.27M | -56.9% | -17.4% |
| December 31, 2024 | $7.59M | -60.6% | -51.9% |
| September 30, 2024 | $15.78M | -31.8% | -17.4% |
| June 30, 2024 | $19.10M | -31.4% | +31.2% |
| March 31, 2024 | $14.56M | -55.4% | -24.4% |
| December 31, 2023 | $19.25M | -47.5% | -16.9% |
- Matinas BioPharma Holdings, Inc. showed a decrease of -36.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Matinas BioPharma Holdings, Inc.’s stockholders equity has grown by 4242.7% (from -$116.6 thousand to $4.83 million).
- The most recent figure is from Matinas BioPharma Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: